TCL Archive With No Budget in Sight, NCI Takes Careful Steps; Success Rate Last Year Was 14 percent November 18, 2011
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005
TCL Archive ACCC To Ask Congress To Earmark Appropriations For Construction Of Community Cancer Centers January 17, 1975